Puma Biotechnology, Inc. SEC filings PBYI

Puma Biotechnology, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Oct 25, 2012. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.

Puma Biotechnology, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 6, 2026 —
4 Insider transaction Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
144 Notice of proposed sale Sep 14, 2026 —
144 Notice of proposed sale Sep 14, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
4 Insider transaction Jul 8, 2026 Jul 6, 2026
4 Insider transaction Jul 8, 2026 Jul 6, 2026
4 Insider transaction Jul 8, 2026 Jul 6, 2026
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
8-K Current report
Shareholder vote results
Jun 16, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
144 Notice of proposed sale Jun 12, 2026 —
144 Notice of proposed sale Jun 12, 2026 —
144 Notice of proposed sale Jun 12, 2026 —
144 Notice of proposed sale Jun 12, 2026 —
144 Notice of proposed sale Jun 12, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
DEFA14A Additional proxy material Apr 28, 2026 —
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 28, 2026 Jun 11, 2026
PRE 14A Preliminary proxy statement Apr 7, 2026 Jun 11, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
4 Insider transaction Nov 13, 2025 Nov 11, 2025
144 Notice of proposed sale Nov 12, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
10-Q/A Amended quarterly report Aug 7, 2025 Mar 31, 2025
4 Insider transaction Jul 22, 2025 Jul 18, 2025
144 Notice of proposed sale Jul 18, 2025 —
4 Insider transaction Jul 10, 2025 Jul 8, 2025
4 Insider transaction Jul 10, 2025 Jul 8, 2025
4 Insider transaction Jul 10, 2025 Jul 8, 2025
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 8, 2025 —
144 Notice of proposed sale Jul 8, 2025 —
144 Notice of proposed sale Jul 8, 2025 —
8-K Current report
Bylaw or fiscal year change
Jun 24, 2025 Jun 19, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
144 Notice of proposed sale Jun 13, 2025 —
144 Notice of proposed sale Jun 13, 2025 —
144 Notice of proposed sale Jun 13, 2025 —
144 Notice of proposed sale Jun 13, 2025 —
8-K Current report
Shareholder vote results
Jun 13, 2025 Jun 11, 2025
144 Notice of proposed sale Jun 13, 2025 —
144 Notice of proposed sale Jun 13, 2025 —
144 Notice of proposed sale May 21, 2025 —
8-K Current report
Officer or director change
May 9, 2025 May 8, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
DEFA14A Additional proxy material Apr 28, 2025 —
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 28, 2025 Jun 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 11, 2025 Feb 7, 2025
4 Insider transaction Feb 11, 2025 Feb 7, 2025
4 Insider transaction Feb 11, 2025 Feb 7, 2025
4 Insider transaction Feb 11, 2025 Feb 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 3, 2025 —
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
SC 13G Ownership over 5% (passive) Oct 22, 2024 —
8-K Current report
Other events
Sep 16, 2024 Sep 12, 2024
S-8 Employee stock plan registration Aug 27, 2024 —
8-K Current report
Other events
Aug 15, 2024 Aug 14, 2024
4 Insider transaction Aug 13, 2024 Aug 12, 2024
144 Notice of proposed sale Aug 12, 2024 —
8-K Current report
Other events
Aug 7, 2024 Aug 6, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 1, 2024 Aug 1, 2024
4 Insider transaction Jul 18, 2024 Jul 17, 2024
4 Insider transaction Jul 18, 2024 Jul 17, 2024
4 Insider transaction Jul 18, 2024 Jul 17, 2024
4 Insider transaction Jul 18, 2024 Jul 17, 2024
144 Notice of proposed sale Jul 17, 2024 —
144 Notice of proposed sale Jul 17, 2024 —
144 Notice of proposed sale Jul 17, 2024 —
144 Notice of proposed sale Jul 17, 2024 —
4 Insider transaction Jul 2, 2024 Jul 2, 2024
4 Insider transaction Jul 2, 2024 Jul 2, 2024
4 Insider transaction Jul 2, 2024 Jul 2, 2024
4 Insider transaction Jul 2, 2024 Jul 2, 2024
144 Notice of proposed sale Jul 2, 2024 —
144 Notice of proposed sale Jul 2, 2024 —
144 Notice of proposed sale Jul 2, 2024 —
144 Notice of proposed sale Jul 2, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 24, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
144 Notice of proposed sale Jun 13, 2024 —
144 Notice of proposed sale Jun 13, 2024 —
144 Notice of proposed sale Jun 13, 2024 —
144 Notice of proposed sale Jun 13, 2024 —
144 Notice of proposed sale Jun 13, 2024 —
8-K Current report
Other events
May 17, 2024 May 17, 2024
10-Q Quarterly report May 2, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 2, 2024 May 2, 2024
DEFA14A Additional proxy material Apr 26, 2024 —
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 26, 2024 Jun 18, 2024
SC 13G Ownership over 5% (passive) Mar 29, 2024 —
4 Insider transaction Mar 19, 2024 Mar 15, 2024
8-K Current report
Other events
Mar 19, 2024 Mar 18, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 29, 2024 Feb 29, 2024
4 Insider transaction Feb 14, 2024 Feb 12, 2024
4 Insider transaction Feb 14, 2024 Feb 12, 2024
4 Insider transaction Feb 14, 2024 Feb 12, 2024
4 Insider transaction Feb 14, 2024 Feb 12, 2024
4 Insider transaction Feb 14, 2024 Feb 12, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 30, 2024 —
8-K Current report
Regulation FD disclosure
Jan 18, 2024 Jan 18, 2024
4 Insider transaction Jan 10, 2024 Dec 4, 2023
144/A Filing Jan 10, 2024 —
4 Insider transaction Jan 5, 2024 Jan 3, 2024
4 Insider transaction Jan 5, 2024 Jan 3, 2024
4 Insider transaction Jan 5, 2024 Jan 3, 2024
4 Insider transaction Jan 5, 2024 Jan 3, 2024
4 Insider transaction Jan 5, 2024 Jan 3, 2024
144 Notice of proposed sale Jan 3, 2024 —
144 Notice of proposed sale Jan 3, 2024 —
144 Notice of proposed sale Jan 3, 2024 —
144 Notice of proposed sale Jan 3, 2024 —
144 Notice of proposed sale Jan 3, 2024 —
4 Insider transaction Nov 9, 2023 Nov 7, 2023
144 Notice of proposed sale Nov 7, 2023 —
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
8-K Current report
Regulation FD disclosure
Sep 26, 2023 Sep 26, 2023
SC 13G Ownership over 5% (passive) Sep 1, 2023 —
8-K Current report
Bylaw or fiscal year change
Aug 18, 2023 Aug 17, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PBYI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Los Angeles, CA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1401667
Former names
INNOVATIVE ACQUISITIONS CORP (until Oct 4, 2011)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.